CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 113 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $678,539 | +3891.4% | 45,509 | +708.6% | 0.00% | – |
| Q2 2022 | $17,000 | -26.1% | 5,628 | -22.4% | 0.00% | – |
| Q1 2022 | $23,000 | -8.0% | 7,256 | 0.0% | 0.00% | – |
| Q4 2021 | $25,000 | +13.6% | 7,256 | +20.6% | 0.00% | – |
| Q3 2021 | $22,000 | -15.4% | 6,015 | 0.0% | 0.00% | – |
| Q2 2021 | $26,000 | -3.7% | 6,015 | 0.0% | 0.00% | – |
| Q1 2021 | $27,000 | +35.0% | 6,015 | +71.9% | 0.00% | – |
| Q4 2020 | $20,000 | -20.0% | 3,500 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |